5 results
diabetes agonists allopurinol anthracycline antiarrhythmics cardiotoxicity classes glp1 gout her2 inhibitors management oncology phases renal toxicity uricacid
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Management #Diabetes #DM2 ... #Endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
very similar to DPP4s ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
Antiarrhythmics Pharmacology Summary Cardiac Conduction Phases: Phase 0 - Ventricular Depolarization: • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Transient K+ efflux moving ... #Classification ... #Classes #pathophysiology ... #phases #cardiology
Allopurinol Pharmacology Summary Xanthine oxidase inhibitor blocking the formation of new uric acid Initiate 1-2 days prior to
Allopurinol Pharmacology ... days prior to chemotherapy ... Dosing: 100 mg ... /m2/dose every 8 ... #pathophysiology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity Anthracyclines cause cardiomyopathy: ✖ Reduction in left ventricular ejection fraction
, 350 mg/m2, and ... every 3 months during ... Cardiotoxicity #cardiology ... #oncology #pharmacology ... #toxicity #chemotherapy
No results found for "Endocrinology pharmacology pathophysiology cardiology dm2 dpp4 dosing chemotherapy classification"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Endocrinology #pharmacology #pathophysiology #cardiology #dm2 #dpp4 #dosing #chemotherapy #classification